Ekaterina S Shchegravina

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 9

Top Topics

Metastatic Renal Cell Carcinoma

Mass Spectrometry

Tyrosine Kinase

Cell Cycle Arrest

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Iuliia A Gracheva, Elena V Svirshchevskaya, Ekaterina S Shchegravina, Yulia B Malysheva, Alsu R Sitdikova, Alexey Yu Fedorov
Design, Synthesis and In Vitro Biological Activity of Novel C-7 Methylene Congeners of Furanoallocolchicinoids. Pharmaceutics 15 (4) (2023)
Iuliia A Gracheva, Elena V Svirshchevskaya, Ekaterina S Shchegravina, Yulia B Malysheva, Alsu R Sitdikova, Alexey Yu Fedorov
Design, Synthesis and In Vitro Biological Activity of Novel C-7 Methylene Congeners of Furanoallocolchicinoids. Pharmaceutics 15 (4) (2023)
Iuliia A Gracheva, Elena V Svirshchevskaya, Ekaterina S Shchegravina, Yulia B Malysheva, Alsu R Sitdikova, Alexey Yu Fedorov
Design, Synthesis and In Vitro Biological Activity of Novel C-7 Methylene Congeners of Furanoallocolchicinoids. Pharmaceutics 15 (4) (2023)
Iuliia A Gracheva, Elena V Svirshchevskaya, Ekaterina S Shchegravina, Yulia B Malysheva, Alsu R Sitdikova, Alexey Yu Fedorov
Design, Synthesis and In Vitro Biological Activity of Novel C-7 Methylene Congeners of Furanoallocolchicinoids. Pharmaceutics 15 (4) (2023)
Anastasia A Sachkova, Daria V Andreeva, Alexander S Tikhomirov, Alexander M Scherbakov, Diana I Salnikova, Danila V Sorokin, Fedor B Bogdanov, Yulia D Rysina, Andrey E Shchekotikhin, Ekaterina S Shchegravina, Alexey Yu Fedorov
Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. Pharmaceutics 14 (12) (2022)
Maria V Zapevalova, Ekaterina S Shchegravina, Irina P Fonareva, Diana I Salnikova, Danila V Sorokin, Alexander M Scherbakov, Alexander A Maleev, Stanislav K Ignatov, Ivan D Grishin, Alexander N Kuimov, Mariya Vladimirovna Konovalova, Elena V Svirshchevskaya, Alexey Yu Fedorov
Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K/Akt/mTOR Pathway. International journal of molecular sciences 23 (18) (2022)
Anastasia A Sachkova, Daria V Andreeva, Alexander S Tikhomirov, Alexander M Scherbakov, Diana I Salnikova, Danila V Sorokin, Fedor B Bogdanov, Yulia D Rysina, Andrey E Shchekotikhin, Ekaterina S Shchegravina, Alexey Yu Fedorov
Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. Pharmaceutics 14 (12) (2022)
Anastasia A Sachkova, Daria V Andreeva, Alexander S Tikhomirov, Alexander M Scherbakov, Diana I Salnikova, Danila V Sorokin, Fedor B Bogdanov, Yulia D Rysina, Andrey E Shchekotikhin, Ekaterina S Shchegravina, Alexey Yu Fedorov
Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. Pharmaceutics 14 (12) (2022)
Anastasia A Sachkova, Daria V Andreeva, Alexander S Tikhomirov, Alexander M Scherbakov, Diana I Salnikova, Danila V Sorokin, Fedor B Bogdanov, Yulia D Rysina, Andrey E Shchekotikhin, Ekaterina S Shchegravina, Alexey Yu Fedorov
Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. Pharmaceutics 14 (12) (2022)